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The purpose of this study was to determine whether acetylation
of the sulfonamide drugs in the human body could be prevented by
substituting a simple alkyl radicle on the amino group of the drug
without otherwise impairing the efficiency of its therapeutic action.
Methyl and dimethyl substituted sulfanilamides were made and
investigated from a pharmacological and therapeutic viewpoint.
Because of the theoretical implications these drugs were tested for
their action in vitro. Although it has been stated that alkyl substi-
tuted compounds of this nature are less active in vivo2'4 than sul-
fanilamide, the only compounds that have been described are the
acylalkyl derivative, acetylmethyl sulfanilamide,l and the arylalkyl
derivative, benzyl sulfanilamide.3
Synthesis
Methyl sulfanilamide was made according to the method out-
lined by Smiles and Stewart8 for acetaminosulfonylchloride and
applied by Miller, Rock, and Moore6 to acyl substituted sulfanil-
amides. About 75 gm. of methylacetanilide were added slowly with
mechanical stirring to 165 cc. of redistilled chlorosulfonic acid sur-
rounded by a freezing-mixture. The mixture was then heated to
650 C. for 18 hours. The resulting syrup was cooled and added to
a kilogram of ice in a vessel surrounded by a freezing-mixture. The
precipitated methylacetylaminobenzenesulfonylchloride was filtered
off and dried on a porous plate and then in a vacuum desiccator. The
dry precipitate, m.p. 1380 C., was added slowly with mechanical
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stirring to 500 cc. of concentrated ammonia. The methylacetyl-
aminobenzenesulfonamide thus obtained was washed and then
hydrolysed by boiling with 15 per cent hydrochloric acid. Free
methyl sulfanilamide was precipitated by neutralization with sodium
hydroxide and recrystalized from ethyl alcohol and water with an
over-all yield of 40 per cent. Methyl sulfanilamide is a white
crystalline substance melting at 1640 C. Upon heating it with
acetic anhydride, acetylmethylsulfanilamide was again obtained
and found to melt at 1510 C., in agreement with the melting point
of 1530 C. described by Buttle.' Nitrogen determination for
methylsulfanilamide (C7H1002N2S) showed 14.7 per cent; the
theoretical value is 15.0 per cent. A sample of methylsulfanilamide
was treated with nitrous acid and dimethylnaphthylamine and no
color was produced. Solubility in water at 250 C. = 166 mg.%.
Dimethylsulfanilamide was synthesized bythe reactions described
above. About 60 gm. ofvacuum-distilled dimethylaniline was added
to 165 cc. of redistilled chlorosulfonic acid. The reaction was slow
and incomplete even after 36 hours at 900 C. Dimethylaminoben-
zenesulfonylchloride has a brilliant yellow color and melts at
1060 C., as described by Schweitzer.7 Dimethylsulfanilamide crys-
tallizes in leaflets melting at 2130 C. The over-all yield was less
than 5 per cent. Nitrogen determination showed (C8HI202N2S)
13.7 per cent; theoretical value, 13.7 per cent. Solubility in water
at 250 C. 13 mg.%. (Hydrolysis of the sulfonyl chloride
yielded a free acid from which the barium salt could be obtained as
needle-shaped crystals described by Meisenheimer.')
Pharmacological properties
Although the relative toxicity of the compounds was not deter-
mined, four of five mice injected subcutaneously with methylsulf-
anilamide (5 gm. per kg. of body weight) suspended in saline and
acacia succumbed to convulsions shortly after the injection. No
toxic effects were noted from therapeutic doses.
The blood level of diazotizable substances (expressed as sul-
fanilamide) was determined in patients and in pooled blood from
several mice given the drugs. (See Table 1.)
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TABLE 1
BLOOD LEVEL OF DIAZOTIZABLE SUBSTANCES, EXPRESSED AS MG. SULFANILAMIDE PER
100 CC. OF BLOOD, AFTER THE ADMINISTRATION OF METHYL OR DIMETHYL
SULFANILAMIDE ORALLY OR SUBCUTANEOUSLY TO HUMAN BEINGS OR TO
20-GM. MICE
Hourp after dose was given
Animal Compound Mg. Route 2-3 4-5 6-8 10-12 2D-22
mice methylsulf- 20 p. o. 39 .. 5.2 1.7
anilamide
mice* methylsulf- 20 s. c. .. 10.6 .. 4.8 0.1
anilamide
mice* dimethylsulf- 20 p. o. 4.6 ..
anilamide
mice* dimethylsulf- 20 s. c. 1.3 .. .. 1.9 2.0
anilamide
man methylsulf- 2000 P. o. .. 1.5 .. 1.2
anilamide
man dimethylsulf- 2000 P. o. .. 0.6 .. trace
anilamide
* Pooled blood from several mice.
Therapeutic properties
Adult Swiss mice weighing about 25 gm. were inoculated intra-
peritoneally with 0.5 cc. of a 106 broth dilution of an 18-hour broth
subculture of beta hemolytic streptococci, strain C 203.* The mice
were treated with subcutaneous injections of 20 mg. of the com-
pound in question, suspended in saline and acacia, one hour after
infection, at subsequent 12-hour intervals for four doses, and finally
once daily for seven days. The results are recorded in Table 2.
TABLE 2
No. Survivors listed at daily intervals after infection
mice Treatment 1 2 3 4 5 6 7 8 9 10 11 1213
25 sulfanil- 25 23 13 7 5 4 4 3 1
25 methylsulf
- 23 17 10 9 7 6 5 1 0 0 0 0 anil0mide
30 none O 0 0 0 0 0 0 0 0 0| 0 0 O
A 10 mg.% broth9 solution ofsulfanilamide or its derivative was
prepared and autoclaved at 1100 C., and S cc. portions of this were
inoculated with 0.2 cc. of a 10-' dilution of a 4-hour broth culture of
the organism in question. The initial bacterial concentration was
* Furnished through the courtesy of Dr. Perrin H. Long.
113YALE JOURNAL OF BIOLOGY AND MEDICINE
between 300 and 500 organisms per cubic centimeter. The broth,
bacteria, and drug mixtures were incubated at 390 C. in the case of
the hemolytic streptococcus C 203 and the type I pneumococcus,
and at 410 C. for cultures of Streptococcus viridans. If "no growth"
was observed after incubation for 48 hours, 1.0 cc. of the mixture was
subcultured into 9 cc. of blood-broth and incubated for 72 hours to
see if the original mixture was "sterile." The results of three
experiments done in duplicate are summarized in Table 3.
TABLE 3
Drug employed in the Organism in the broth, bacteria, and drug mixture
broth, bacteria, and
drug mixture hem. strep. type I pneumo. Strep. vir.
Sulfanilamide sterile sterile sterile
Methylsulfanilamide sterile growth growth
Dimethylsulfanilamide sterile growth growth
Broth control growth growth growth
Sulfanilamide sterile sterile sterile
Methylsulfanilamide sterile growth growth
Dimethylsulfanilamide no growth* growth growth
Broth contiol growth growth growth
Sulfanilamide sterile sterile sterile
Methylsulfanilamide no growth* growth growth
Dimethylsulfanilamide growth growth growth
Broth control growth growth growth
* No growth observed at 48 hours, but subculture showed growth.
The inconstant results obtained with the dimethyl substituted
compound may be due to the fact that all of it did not go into solu-
tion in the broth mixture. No diazotizable substance (sulfanil-
amide) could be detected in the broth cultures that were sterilized
by the methyl and dimethyl sulfanilamides.
Discussion
Although the initial objective of these experiments was not
attained, certain pertinent observations may be made. The intro-
duction of methyl radicles into the amino group of sulfanilamide
renders it less soluble, the dimethyl substituted compound being less
soluble than is the monomethyl compound. Although the methyl
substituted sulfanilamides are stable in boiling aqueous, acidic, or
alcoholic solutions, they are promptly demethylated in the human
bodyand in the mouse, yielding presumably sulfanilamide. Methyl-
sulfanilamide is therapeutically active in mouse infection with the
beta hemolytic streptococcus. Methylsulfanilamide is bactericidal to
the hemolytic streptococcus when tested in vitro, although no break-
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down to sulfanilamide was found. Neither of the methyl substi-






ide, and p(dimethylamino)benzenesulfonamide (N4dimethylsulf-
anilamide) have been synthesized and characterized.
Methylsulfanilamide is an active chemotherapeutic agent against
the beta hemolytic streptococcus. Dimethyl and methyl sulfanil-
amides are demethylated when administered to the human being or
to the mouse. Methylsulfanilamide is streptococcidal in vitro.
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